RHYTHM BIOSCIENCES ORDINARY (RHY) Short Interest

Rhythm Biosciences is an Australian medical diagnostics company focused on developing and commercializing innovative diagnostic technologies for early cancer detection. Their primary focus is ColoSTAT, a non-invasive blood test for the early detection of colorectal cancer, offering a more accessible alternative to traditional screening methods. Rhythm aims to transform cancer diagnostics by providing precise and accessible screening solutions, empowering patients and healthcare systems with critical insights.